Tradestie Institutional Equity Comparison Engine

CRBU vs MXCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MXCT Overall Edge

MXCT Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MaxCyte, Inc. Common Stock (MXCT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CRBU trades at N/M Forward P/E with -1140.6% operating margin (-26.9% YoY revenue) versus MXCT at N/M Forward P/E and -85.5% operating margin (+48.7% YoY). In options structure, CRBU sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CRBU N/M vs MXCT N/M Fwd P/E
Growth & Margin Winner MXCT
Op Margin -1140.6% vs -85.5% ยท YoY -26.9% vs +48.7%
Momentum & Technical Winner MXCT
1Y -84.4% vs -19.4% ยท 52W Pos 0% vs 63%
Options & Structure Winner MXCT
BREAKDOWN (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
CRBU NASDAQ
Caribou Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.28
-8.44% 1D
Market Cap $33.5M
1M Return -49.23%
1Y Return -84.38%
Forward P/E N/M
Unified AI Score
46.4 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 68.0 Mom 59.0
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRBU -84.38% MXCT -19.41% Spread: +64.97 pp (MXCT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRBU Revenue MXCT Revenue CRBU Op. Margin MXCT Op. Margin Margin Edge
FY2019 $10M $10M -592.7% -93.7% MXCT
FY2020 $10M $20M -292.2% -71.6% MXCT
FY2021 $10M $20M -697.8% -84.3% MXCT
FY2022 $10M $30M -768.2% -95.2% MXCT
FY2023 $30M $20M -336.6% -247.7% MXCT
FY2024 $10M $20M -1667.2% -230.5% MXCT
FY2025 $10M $20M -1329.4% -247.6% MXCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRBU (3) vs MXCT (5)
Institutional Metric CRBU MXCT Criterion Row Winner
Market Capitalization Scale $33.5M $132.2M Larger Scale MXCT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -26.9% +48.7% Higher Growth MXCT
Operating Margin (TTM) Profitability -1140.6% -85.5% Higher Margin MXCT
Net Profit Margin Profitability 0.0% -81.4% Higher Margin CRBU
Return on Equity (ROE) Capital Efficiency -93.8% -16.9% Higher ROE MXCT
52-Week Range Position Momentum 0% ($0โ€“$2) 63% ($1โ€“$2) Stronger Trend MXCT
Beta / 30D Volatility Risk Regime 1.56ฮฒ ยท 74% Vol 1.19ฮฒ ยท 96% Vol Lower Realized Risk CRBU
Unified Institutional Score Composite Signal 46.4 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite CRBU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRBU vs MXCT Buy Guide
CRBU BREAKDOWN
119d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CRBU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRBU nor MXCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.